Sato H, Sato Y, Ito A, Ohishi I
Infect Immun. 1987 Apr;55(4):909-15. doi: 10.1128/iai.55.4.909-915.1987.
Two distinct monoclonal antibodies, one to pertussis toxin subunit S2, called 9G8, and another to subunits S2 and S3, called 11E6, were generated from the hybridomas of myeloma SP2/0 and spleen cells of BALB/c mice immunized mainly with the subunit S234 complex. Binding ability of 9G8 and 11E6 to the subunits was confirmed by the enzyme-linked immunosorbent assay and immunoblotting analysis. Generation of 11E6 bound to both S2 and S3 might mean that there is common antigenicity between S2 and S3. Neutralizing activities of 9G8 and 11E6 on various biological activities of pertussis toxin, including ADP-ribosyltransferase and leukocytosis-promoting, islet-activating, permeability-increasing. Chinese hamster ovary (CHO) cell-clustering, and hemagglutinating activities, were compared with those of anti-S1 monoclonal antibodies 1B7 and 3F10, which were isolated and characterized in a previous study (H. Sato, A. Ito, J. Chiba, and Y. Sato, Infect. Immun. 46:422-428, 1984). 1B7 and 3F10 neutralized ADP-ribosyltransferase activity of pertussis toxin or S1, but 9G8 and 11E6 did not. 1B7 showed very potent neutralization against leukocytosis-promoting, islet-activating, permeability-increasing, and CHO cell-clustering activities of pertussis toxin, but 3F10 did not, although anti-ADP-ribosyltransferase activities of both antibodies were identical. 11E6 neutralized leukocytosis-promoting, islet-activating, CHO cell-clustering, and hemagglutinating activities but not permeability-increasing activity. 9G8 showed slight neutralization of leukocytosis-promoting and CHO cell-clustering activities. Specific activities of 1B7 and 11E6 in each neutralization test were higher than or almost comparable to those of polyclonal antibodies to pertussis toxin. The neutralizing mechanism of 1B7 and 11E6 in leukocytosis-promoting activity was compared. 11E6 seemed to interfere with the binding of pertussis toxin to receptors on mouse spleen cells.
从骨髓瘤SP2/0与主要用S234复合物免疫的BALB/c小鼠脾细胞的杂交瘤中,产生了两种不同的单克隆抗体,一种针对百日咳毒素亚基S2,称为9G8,另一种针对亚基S2和S3,称为11E6。通过酶联免疫吸附测定和免疫印迹分析证实了9G8和11E6与这些亚基的结合能力。与S2和S3都结合的11E6的产生可能意味着S2和S3之间存在共同抗原性。将9G8和11E6对百日咳毒素各种生物学活性的中和活性,包括ADP-核糖基转移酶活性、促白细胞增多活性、胰岛激活活性、通透性增加活性、中国仓鼠卵巢(CHO)细胞聚集活性和血凝活性,与先前研究(H. Sato、A. Ito、J. Chiba和Y. Sato,《感染与免疫》46:422 - 428,1984)中分离和鉴定的抗S1单克隆抗体(1B7和3F10)的中和活性进行了比较。1B7和3F10可中和百日咳毒素或S1的ADP-核糖基转移酶活性,但9G8和11E6不能。1B7对百日咳毒素的促白细胞增多活性、胰岛激活活性、通透性增加活性和CHO细胞聚集活性表现出非常强的中和作用,但3F10没有,尽管两种抗体的抗ADP-核糖基转移酶活性相同。11E6可中和促白细胞增多活性、胰岛激活活性、CHO细胞聚集活性和血凝活性,但不能中和通透性增加活性。9G8对促白细胞增多活性和CHO细胞聚集活性表现出轻微的中和作用。在每次中和试验中,1B7和11E6的比活性高于或几乎与百日咳毒素多克隆抗体的比活性相当。比较了1B7和11E6在促白细胞增多活性方面的中和机制。11E6似乎干扰了百日咳毒素与小鼠脾细胞上受体的结合。